UAE sets up $150M biologics plant

Abu Dhabi, which is part of the United Arab Emirates, is setting up $150 million biologics manufacturing plant that will produce crystal insulin for diabetes, anti-cancers, vaccines, haemophilia A and growth factors for the Middle East and North Africa. The plant is part of the region's plan to expand its industry beyond oil. Report